ALEXANDRIA, Va., May 12 -- United States Patent no. 12,624,066, issued on May 12, was assigned to Sunshine Biopharma Inc. (Centennial, Colo.).
"Inhibitors of coronavirus protease" was invented by Steve N. Slilaty (Laval, Canada).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present document describes compounds that are inhibitors of coronavirus proteases, and more particularly to compounds that are inhibitors of SARS-CoV-2 viral proteases. Also, the present document describes methods and uses of the compounds for the treatment or prevention of viral infection, such as SARS-CoV-2 infections, in a subject in need of treatment."
The patent was filed on April 30, 2021, under Application No. 17/926,892.
*Fo...